# STROBE-CI Checklist for Causal Inference Studies

## Title and Abstract

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 1a | Indicate study design in title | Title | ✓ |
| 1b | Provide informative abstract | Abstract | ✓ |

## Introduction

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 2 | Background/rationale | p.2, lines 45-89 | ✓ |
| 3 | State causal objectives | p.3, lines 125-130 | ✓ |

## Methods

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 4 | Study design | p.4, lines 156-162 | ✓ |
| 5 | Setting | p.4, lines 163-170 | ✓ |
| 6 | Participants | p.4, lines 171-185 | ✓ |
| 7 | Variables | p.5, lines 186-215 | ✓ |
| 8 | Data sources | p.5, lines 216-225 | ✓ |
| 9 | Bias | p.6, lines 256-270 | ✓ |
| 10 | Study size | p.6, lines 271-280 | ✓ |
| 11 | Quantitative variables | p.7, lines 281-295 | ✓ |
| 12 | Statistical methods | p.7-8, lines 296-350 | ✓ |

## Causal Inference Specific Items

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| CI-1 | Target trial emulation | p.8, lines 351-365 | ✓ |
| CI-2 | Causal diagram (DAG) | Figure 1, p.9 | ✓ |
| CI-3 | Identifiability assumptions | p.8, lines 366-380 | ✓ |
| CI-4 | Positivity assessment | p.9, lines 381-390 | ✓ |
| CI-5 | Multiple versions of treatment | p.9, lines 391-400 | ✓ |

## Results

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 13 | Participants | p.10, lines 401-415 | ✓ |
| 14 | Descriptive data | Table 1, p.11 | ✓ |
| 15 | Outcome data | p.12, lines 450-465 | ✓ |
| 16 | Main results | Table 2, p.13 | ✓ |
| 17 | Other analyses | p.14, lines 500-525 | ✓ |

## Discussion

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 18 | Key results | p.15, lines 526-540 | ✓ |
| 19 | Limitations | p.16, lines 541-560 | ✓ |
| 20 | Interpretation | p.17, lines 561-580 | ✓ |
| 21 | Generalizability | p.17, lines 581-595 | ✓ |

## Other Information

| Item | Recommendation | Page/Line | ✓ |
|------|----------------|-----------|---|
| 22 | Funding | p.18, lines 596-600 | ✓ |
| 23 | Data availability | p.18, lines 601-605 | ✓ |
| 24 | Code availability | p.18, lines 606-610 | ✓ |

---

*Completed: 2025-06-17*
*All items checked and cross-referenced to manuscript*
